The Use of START/STOPP Criteria for Elderly Patients in Primary Care

Table 1

Number and percentage of drug inappropriateness according to STOPP criteria.

Drug inappropriateness	𝑛 (no.)	% (perc.)
Therapeutic (NSAID) duplication	31	64.6
Use of acetylsalicylic acid at dose >150 mg per day	9	18.8
Therapeutic (NSAID) duplication and acetylsalicylic acid at dose >150 mg per day	2	4.2
Use of NSAID in heart failure and therapeutic (NSAID) duplication	1	2.1
Aspirin and warfarin combination without H2 receptor blocker or proton pump inhibitor (PPI) and use of acetylsalicylic acid at dose >150 mg per day	1	2.1
Aspirin and warfarin combination without H2 receptor blocker or proton pump inhibitor	1	2.1
Use of warfarin in combination with NSAID (increased risk for gastrointestinal bleeding)	1	2.1
Use of calcium channel blocker in chronic constipation	1	2.1
Use of beta2 agonist or anticholinergic for mild-mediate chronic obstructive pulmonary disease (COPD) or asthma	1	2.1
Total	48	100.0